ライブラリ登録: Guest
Critical Reviews™ in Oncogenesis

年間 4 号発行

ISSN 印刷: 0893-9675

ISSN オンライン: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

C/EBPα Dysregulation in AML and ALL

巻 16, 発行 1-2, 2011, pp. 93-102
DOI: 10.1615/CritRevOncog.v16.i1-2.90
Get accessGet access

要約

The transcription factor CCAAT/enhancer binding protein a (C/EBPα) is a critical regulator of myeloid development, directing granulocyte, and monocyte differentiation. As such, it is dysregulated in more than half of patients with acute myeloid leukemia (AML). C/EBPα expression is suppressed as result of common leukemia-associated genetic and epigenetic alterations such as AML1-ETO, BCR-ABL, FLT3-ITD, or CEBPA promoter methylation. In addition, 10-15% of patients with AML with intermediate risk cytogenetics are characterized by mutations of the CEBPA gene. Two classes of mutations are described. N-terminal changes result in expression of a truncated dominant negative C/EBPαp30 isoform. C-terminal mutations are in-frame insertions or deletions resulting in alteration of the leucine zipper preventing dimerization and DNA binding. Often, patients carry both N- and C-terminal mutations each affecting a different allele, and a mouse model recapitulates the human phenotype. Patients with mutated CEBPA AML comprise a clinically distinct group with favorable outcome consistently seen in patients with biallelic mutations. In addition, C/EBP family members are aberrantly expressing from the immunoglobulin heavy chain locus in 2% of pre-B ALLs. This review summarizes the normal hematopoietic developmental pathways regulated by C/EBPα and discusses the molecular pathways involved in mutated CEBPA AML and ALL.

によって引用された
  1. Wertheim Gerald B. W., Hexner Elizabeth, Bagg Adam, Molecular-Based Classification of Acute Myeloid Leukemia and Its Role in Directing Rational Therapy, Molecular Diagnosis & Therapy, 16, 6, 2012. Crossref

  2. Han Youqi, Cui Jie, Lu Yan, Sue Stephanie, Arpaia Enrico, Mak Tak W., Minden Mark D., FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients, Leukemia Research, 36, 11, 2012. Crossref

  3. Kassem Neemat, Fahmy Abd El-Gawad, Desoky Mohamed, Medhat Nashwa, Zawam Hamdy M., CCAAT/enhancer binding protein α gene expression in Egyptian patients with acute myeloid leukemia, Journal of the Egyptian National Cancer Institute, 25, 3, 2013. Crossref

  4. Chen-Deutsch Xiangwen, Studzinski George P., Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance, Cell Cycle, 11, 7, 2012. Crossref

  5. Tidwell Timothy, Wechsler Jeremy, Nayak Ramesh C., Trump Lisa, Salipante Stephen J., Cheng Jerry C., Donadieu Jean, Glaubach Taly, Corey Seth J., Grimes H. Leighton, Lutzko Carolyn, Cancelas Jose A., Horwitz Marshall S., Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms, Blood, 123, 4, 2014. Crossref

  6. Federzoni Elena A., Humbert Magali, Torbett Bruce E., Behre Gerhard, Fey Martin F., Tschan Mario P., CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation, Scientific Reports, 4, 1, 2015. Crossref

  7. Barbagallo Davide, Condorelli Angelo Giuseppe, Piro Salvatore, Parrinello Nunziatina, Fløyel Tina, Ragusa Marco, Rabuazzo Agata Maria, Størling Joachim, Purrello Francesco, Di Pietro Cinzia, Purrello Michele, Tansey William P., CEBPA exerts a specific and biologically important proapoptotic role in pancreatic β cells through its downstream network targets, Molecular Biology of the Cell, 25, 16, 2014. Crossref

  8. Godley Lucy A., Inherited Predisposition to Acute Myeloid Leukemia, Seminars in Hematology, 51, 4, 2014. Crossref

  9. Larsen Maria T., Häger Mattias, Glenthøj Andreas, Asmar Fazila, Clemmensen Stine N., Mora-Jensen Helena, Borregaard Niels, Cowland Jack B., miRNA-130a regulates C/EBP-ε expression during granulopoiesis, Blood, 123, 7, 2014. Crossref

  10. Pulido-Salgado Marta, Vidal-Taboada Jose M., Saura Josep, C/EBPβ and C/EBPδ transcription factors: Basic biology and roles in the CNS, Progress in Neurobiology, 132, 2015. Crossref

  11. Wertheim Gerald B. W., Molecular characterization and testing in acute myeloid leukemia, Journal of Hematopathology, 8, 3, 2015. Crossref

  12. Friedman Alan D., C/EBPα in normal and malignant myelopoiesis, International Journal of Hematology, 101, 4, 2015. Crossref

  13. Chlebowska Justyna, Stres siateczki śródplazmatycznej i stres oksydacyjny w ostrych białaczkach szpikowych, Acta Haematologica Polonica, 47, 3, 2016. Crossref

  14. Anguita Eduardo, Candel Francisco J., Chaparro Alberto, Roldán-Etcheverry Juan J., Transcription Factor GFI1B in Health and Disease, Frontiers in Oncology, 7, 2017. Crossref

  15. Salarpour Fatemeh, Goudarzipour Kourosh, Mohammadi Mohammad Hossein, Ahmadzadeh Ahmad, Faraahi Sara, Farsani Mehdi Allahbakhshian, Evaluation of CCAAT/Enhancer Binding Protein (C/EBP) Alpha (CEBPA) and Runt-Related Transcription Factor 1 (RUNX1) Expression in Patients with De Novo Acute Myeloid Leukemia, Annals of Human Genetics, 81, 6, 2017. Crossref

  16. Valiulienė Giedrė, Stirblytė Ieva, Jasnauskaitė Monika, Borutinskaitė Veronika, Navakauskienė Rūta, Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells, European Journal of Pharmacology, 799, 2017. Crossref

  17. TAO YAN-FANG, HU SHAO-YAN, LU JUN, CAO LAN, ZHAO WEN-LI, XIAO PEI-FANG, XU LI-XIAO, LI ZHI-HENG, WANG NA-NA, DU XIAO-JUAN, SUN LI-CHAO, ZHAO HE, FANG FANG, SU GUANG-HAO, LI YAN-HONG, LI YI-PING, XU YUN-YUN, NI JIAN, WANG JIAN, FENG XING, PAN JIAN, Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients, International Journal of Molecular Medicine, 34, 6, 2014. Crossref

  18. Guo Hong, Ma Ou, Friedman Alan D., TheCebpa+37-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells, Journal of Leukocyte Biology, 96, 3, 2014. Crossref

  19. Bonifer Constanze, Cockerill Peter N., Ptasinska Anetta, Aberrant Transcriptional Programming in Blood Cancers, in Chromosomal Translocations and Genome Rearrangements in Cancer, 2015. Crossref

  20. Bertoli Sarah, Boutzen Helena, David Laure, Larrue Clément, Vergez François, Fernandez-Vidal Anne, Yuan Lingli, Hospital Marie-Anne, Tamburini Jérôme, Demur Cécile, Delabesse Eric, Saland Estelle, Sarry Jean-Emmanuel, Galcera Marie-Odile, Mas Véronique Mansat-De, Didier Christine, Dozier Christine, Récher Christian, Manenti Stéphane, CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia, Oncotarget, 6, 35, 2015. Crossref

  21. Liang Yuanxin, Yu Dong, Perez-Soler Roman, Klostergaard Jim, Zou Yiyu, TRIB2 contributes to cisplatin resistance in small cell lung cancer, Oncotarget, 8, 65, 2017. Crossref

  22. Zhou Jianbiao, Ching Ying Qing, Chng Wee-Joo, Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target, Oncotarget, 6, 8, 2015. Crossref

  23. Calura Enrica, Bisognin Andrea, Manzoni Martina, Todoerti Katia, Taiana Elisa, Sales Gabriele, Morgan Gareth J., Tonon Giovanni, Amodio Nicola, Tassone Pierfrancesco, Neri Antonino, Agnelli Luca, Romualdi Chiara, Bortoluzzi Stefania, Disentangling the microRNA regulatorymilieuin multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients, Oncotarget, 7, 3, 2016. Crossref

  24. Brown Anna L., Hahn Christopher N., Scott Hamish S., Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA), Blood, 136, 1, 2020. Crossref

  25. Kang Yefang, Chen Xiuhua, Fang Fang, Zhang Lingli, Wang Jiaxuan, Tian Chuchu, Guo Wenzheng, Xu Jing, Ren Huanying, Muyey Daniel Muteb, Tan Yanhong, Xu Zhifang, Wang Hongwei, The clinical characteristics and prognosis of cytogenetically normal AML with single mutations of CEBPA , International Journal of Laboratory Hematology, 43, 6, 2021. Crossref

  26. Giambruno Roberto, Grebien Florian, Stukalov Alexey, Knoll Christian, Planyavsky Melanie, Rudashevskaya Elena L., Colinge Jacques, Superti-Furga Giulio, Bennett Keiryn L., Affinity Purification Strategies for Proteomic Analysis of Transcription Factor Complexes, Journal of Proteome Research, 12, 9, 2013. Crossref

  27. Qi Xin, Zhang Xintong, Liu Xiaochun, Tang Wei, Dai Jiajia, Chen Ao, Lin Qian, Zhu Tianjiao, Li Jing, HDN-1 induces cell differentiation toward apoptosis in promyelocytic leukemia cells depending on its selective effect on client proteins of Hsp90, Toxicology and Applied Pharmacology, 417, 2021. Crossref

  28. Lohan Fiona, Keeshan Karen, The functionally diverse roles of tribbles, Biochemical Society Transactions, 41, 4, 2013. Crossref

  29. Patterson Shaun D., Huang Xu, Jørgensen Heather G., Michie Alison M., Transcriptional Regulation by the NFAT Family in Acute Myeloid Leukaemia, Hemato, 2, 3, 2021. Crossref

  30. Mészáros Bálint, Hajdu-Soltész Borbála, Zeke András, Dosztányi Zsuzsanna, Mutations of Intrinsically Disordered Protein Regions Can Drive Cancer but Lack Therapeutic Strategies, Biomolecules, 11, 3, 2021. Crossref

  31. Shvachko Lyudmyla, Zavelevich Michael, Gluzman Daniil, Telegeev Gennadii, Vitamin E in Chronic Myeloid Leukemia (CML) Prevention, in Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects, 22, 2021. Crossref

  32. Navakauskienė Rūta, Navakauskas Dalius, Borutinskaitė Veronika, Matuzevičius Dalius, Chromatin Remodeling During Leukemia Cell Proliferation and Differentiation, in Epigenetics and Proteomics of Leukemia, 2021. Crossref

  33. Nie Yuanyuan, Su Long, Li Wei, Gao Sujun, Novel insights of acute myeloid leukemia with CEBPA deregulation: Heterogeneity dissection and re-stratification, Critical Reviews in Oncology/Hematology, 163, 2021. Crossref

  34. Wolff Linda, Humeniuk Rita, Concise Review: Erythroid Versus Myeloid Lineage Commitment: Regulating the Master Regulators, Stem Cells, 31, 7, 2013. Crossref

  35. Mangiagalli Marco, Barbiroli Alberto, Santambrogio Carlo, Ferrari Cristian, Nardini Marco, Lotti Marina, Brocca Stefania, The activity and stability of a cold-active acylaminoacyl peptidase rely on its dimerization by domain swapping, International Journal of Biological Macromolecules, 181, 2021. Crossref

  36. Anderson Erik R., Taylor Matthew, Xue Xiang, Martin Angelical, Moons David S., Omary M. Bishr, Shah Yatrik M., The Hypoxia-Inducible Factor–C/EBPα Axis Controls Ethanol-Mediated Hepcidin Repression, Molecular and Cellular Biology, 32, 19, 2012. Crossref

  37. Alemdehy M F, de Looper H W J, Kavelaars F G, Sanders M A, Hoogenboezem R, Löwenberg B, Valk P J M, Touw I P, Erkeland S J, MicroRNA-155 induces AML in combination with the loss of C/EBPA in mice, Leukemia, 30, 11, 2016. Crossref

  38. Girard Nathalie, Tremblay Mathieu, Humbert Magali, Grondin Benoît, Haman André, Labrecque Jean, Chen Bing, Chen Zhu, Chen Sai-Juan, Hoang Trang, RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells, Proceedings of the National Academy of Sciences, 110, 33, 2013. Crossref

  39. Zhang Zhi-Chun, Liu Yuan, Li Shu-Fen, Guo Liang, Zhao Yue, Qian Shu-Wen, Wen Bo, Tang Qi-Qun, Li Xi, Suv39h1 Mediates AP-2α-Dependent Inhibition of C/EBPα Expression during Adipogenesis, Molecular and Cellular Biology, 34, 12, 2014. Crossref

  40. O'Connor C, Lohan F, Campos J, Ohlsson E, Salomè M, Forde C, Artschwager R, Liskamp R M, Cahill M R, Kiely P A, Porse B, Keeshan K, The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia, Oncogene, 35, 40, 2016. Crossref

  41. Slamova L, Starkova J, Fronkova E, Zaliova M, Reznickova L, van Delft F W, Vodickova E, Volejnikova J, Zemanova Z, Polgarova K, Cario G, Figueroa M, Kalina T, Fiser K, Bourquin J P, Bornhauser B, Dworzak M, Zuna J, Trka J, Stary J, Hrusak O, Mejstrikova E, CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage, Leukemia, 28, 3, 2014. Crossref

  42. Di Francesco Barbara, Verzella Daniela, Capece Daria, Vecchiotti Davide, Di Vito Nolfi Mauro, Flati Irene, Cornice Jessica, Di Padova Monica, Angelucci Adriano, Alesse Edoardo, Zazzeroni Francesca, NF-κB: A Druggable Target in Acute Myeloid Leukemia, Cancers, 14, 14, 2022. Crossref

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain